Ideal Taxes Association

Raymond Richman       -       Jesse Richman       -       Howard Richman

 Richmans' Trade and Taxes Blog



Evidence is in: Hydroxychloroquine works -- I'm published in American Thinker this morning
Howard Richman, 7/5/2020

The media is doing its best to ignore the solid new evidence that hydroxychloroquine (HCQ) works. Although they claim to be pro-science, they only report scientific studies that agree with their narrative. Although they claim that black lives matter to them, they purposely keep knowledge about successful treatments away from COVID-19 patients, a disproportionate number of whom are black. Here are some details of the two new studies that almost all of them are ignoring:

  1. Henry Ford Health System. Last week, the International Journal of Infectious Diseases reported that hydroxychloroquine cuts the death rate in half when it is administered to hospitalized COVID-19 patients soon after they are admitted. The retrospective study of 2,541 patients was conducted by the Henry Ford Health System in Detroit Michigan. Only 13% of the patients who were given HCQ died as compared to 26% who were not given HCQ. HCQ worked whether or not it was given with the antibiotic azithromycin, but it appeared to work slightly better with azithromycin. Key to the study was early treatment with HCQ, with 91% in the HCQ group starting that medication within 48 hours of hospital admission. 
  1. Mount Sinai Hospital. Also last week, Nature Reviews Immunology published the results of the small but ideal type of experiment (a double-blind, randomized clinical trial) conducted by Mount Sinai Hospital in New York which found that 0 of 31 patients in the HCQ group progressed from mild to severe as compared to 4 of 31 patients in the control group.

The media is also ignoring the May 8 study of 932 patients by the New York University Grossman School of Medicine which compared the HCQ/azithromycin treatment with the HCQ/azithromycin/zinc treatment. NYU found that the addition of zinc sulfate pills to the HCQ/azithromycin treatment reduced the death rate from 23% to 13%, but only if given before the patients got so sick that they required intensive care.

If these results are extrapolated, they show that early treatment with HCQ could prevent about 50% of the deaths from COVID-19, and the addition of zinc sulfate could further reduce the death rate by an additional 20%. For every 100 patients who are currently dying without effective pharmacological treatment, only 30 would die if they were treated early with the HCQ/azithromycin/zinc combination.

The studies which appear show that HCQ doesn’t work should be considered as well. Two of them, based upon data provided by a small company named Surgisphere and published in reputable medical journals, were retracted by the journals when it turned out that the data were suspect. And the other studies either overdosed their patients with a toxic dosage of HCQ (200mg to 400mg per day for 5 days is normal), or they often waited until COVID-19 was severe before beginning the HCQ.

The media seems to be exceptionally incurious about why countries in Asia have much lower death rates than those in Europe and America. According to worldometers, only 3 people per million have died in China, 6 per million in South Korea, 8 per million in Japan and 14 per million in India. Compare that with 400 per million in the U.S.A, 537 in Sweden, 651 in UK and 843 in Belgium. You have to read Asian newspapers to learn how COVID-19 patients in Asia are being treated. According to India’s The National Herald:

A Shanghai-based Noida doctor says China is close to winning the battle against COVID-19, and the combination of zinc, hydroxychloroquine (HCQ) and antibiotic azithromycin has been able to save the lives of coronavirus patients.

Speaking to IANS, Dr Sanjeev Choubey, Medical Director Internal Medicine at St. Michael Hospital said this combination has been adopted as a line of treatment for patients infected with coronavirus, and, as a result, patients are recovering, decreasing their need for intensive care.

Unfortunately, the health bureaucracy in Washington DC, has been actively suppressing the use of HCQ in the United States. Economist Peter Navarro, in charge of procuring sufficient COVID-19 treatment supplies for President Trump, had a great interview with America’s Voice on July 3 in which he discussed this week’s HCQ studies, the press ignoring them, and the FDA standing in the way. Here’s what he said about the FDA (at the 12:55 mark):

The next shoe that has to drop here is that the FDA really has to revisit these decisions that it made over the last several months which effectively killed hydroxy demand and also has made it very difficult to conduct the additional clinical trials we need, not just for therapeutic, but also for prophylactics.

The Washington bureaucracy and the mainstream media have blood on their hands. Both continue to kill people by ignoring the scientific studies which show that the HCQ-zinc combo, if given early, could reduce the COVID-19 death rate by about 70%. To the main-stream media, only the lives of thugs killed by the police matter. The lives of COVID-19 patients do not. So, if you get sick, buy some zinc over the counter and, like it says in all the TV ads, talk to your doctor to see if an HCQ prescription might be right for you!

To read it on the American Thinker website, go to: https://www.americanthinker.com/blog/2020/07/evidence_is_in_hydroxychloroquine_works.html

Your Name:

Post a Comment:


Comment by S. Heenan, 7/7/2020:

Can you please provide the link to the Mount Sinai Hospital, study published in the Nature Reviews Immunology?  The link in this article is for the Henry Ford study, not the Mount Sinai study.


Comment by Einat , 7/8/2020:

Thank you for the information 


Comment by Einat , 7/8/2020:

Thank you for the information 




  • Richmans' Blog    RSS
  • Our New Book - Balanced Trade
  • Buy Trading Away Our Future
  • Read Trading Away Our Future
  • Richmans' Commentaries
  • ITA Working Papers
  • ITA on Facebook
  • Contact Us

    Archive
    Jul 2020

    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011
    April 2011
    March 2011
    February 2011
    January 2011
    December 2010
    November 2010
    October 2010
    September 2010
    August 2010
    July 2010
    June 2010
    May 2010
    April 2010
    March 2010
    February 2010
    January 2010

    Categories:
    Book Reviews
    Capital Gains Taxation
    Corporate Income Tax
    Consumption Taxes
    Economy - Long Term
    Economy - Short Term

    Environmental Regulation
    Last 100 Years
    Politics
    Real Estate Taxation
    Trade
    Miscellaneous

    Outside Links:

  • American Economic Alert
  • American Jobs Alliance
  • Angry Bear Blog
  • Economy in Crisis
  • Econbrowser
  • Emmanuel Goldstein's Blog
  • Levy Economics Institute
  • McKeever Institute
  • Michael Pettis Blog
  • Naked Capitalism
  • Natural Born Conservative
  • Science & Public Policy Inst.
  • TradeReform.org
  • Votersway Blog
  • Watt's Up With That


    Wikipedia:

  • [An] extensive argument for balanced trade, and a program to achieve balanced trade is presented in Trading Away Our Future, by Raymond Richman, Howard Richman and Jesse Richman. “A minimum standard for ensuring that trade does benefit all is that trade should be relatively in balance.” [Balanced Trade entry]

    Journal of Economic Literature:

  • [Trading Away Our Future] Examines the costs and benefits of U.S. trade and tax policies. Discusses why trade deficits matter; root of the trade deficit; the “ostrich” and “eagles” attitudes; how to balance trade; taxation of capital gains; the real estate tax; the corporate income tax; solving the low savings problem; how to protect one’s assets; and a program for a strong America....

    Atlantic Economic Journal:

  • In Trading Away Our Future   Richman ... advocates the immediate adoption of a set of public policy proposal designed to reduce the trade deficit and increase domestic savings.... the set of public policy proposals is a wake-up call... [February 17, 2009 review by T.H. Cate]